Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment
- PMID: 1662324
- DOI: 10.1007/BF01744270
Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment
Abstract
We report the case of 43-year-old homosexual patient with HIV infection and a history of travel to the Far East in whom visceral leishmaniasis was the first infectious complication. Symptoms were fever, malaise, weight loss, hepatosplenomegaly, generalized lymphadenopathy, and oral thrush. Laboratory abnormalities included a slight elevation of liver enzymes, impairment of liver function tests, leukocytopenia, anemia, hypergammaglobulinemia, and markedly depressed CD4(+)-cell counts. Despite initially successful treatment with pentavalent antimony, a relapse of leishmaniasis occurred after 7 months. Eradication of the infection was not achieved. Treatment was continued as a palliative chronic suppressive treatment with fortnightly pentamidine infusions. The clinical course was complicated by legionella pneumonia and the development of rapidly progressing Kaposi's sarcoma. The case is presented in detail, and the influence of HIV infection on the course of leishmaniasis is discussed.
Similar articles
-
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?AIDS. 1992 Dec;6(12):1499-503. doi: 10.1097/00002030-199212000-00013. AIDS. 1992. PMID: 1362880
-
Visceral leishmaniasis in an adult with HIV infection.Acta Clin Belg. 1991;46(5):324-6. doi: 10.1080/17843286.1991.11718183. Acta Clin Belg. 1991. PMID: 1661552
-
Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.Trans R Soc Trop Med Hyg. 1985;79(5):705-14. doi: 10.1016/0035-9203(85)90199-3. Trans R Soc Trop Med Hyg. 1985. PMID: 3006295
-
Treatment for visceral leishmaniasis.J Assoc Physicians India. 1987 Sep;35(9):641-3. J Assoc Physicians India. 1987. PMID: 2830224 Review. No abstract available.
-
Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.Ann Trop Med Parasitol. 2009 Jul;103(5):455-9. doi: 10.1179/136485909X451753. Ann Trop Med Parasitol. 2009. PMID: 19583915 Review. No abstract available.
Cited by
-
Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.Am J Pathol. 1995 Mar;146(3):635-42. Am J Pathol. 1995. PMID: 7887446 Free PMC article.
-
Visceral Leishmaniasis and HIV coinfection in East Africa.PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2869. doi: 10.1371/journal.pntd.0002869. eCollection 2014 Jun. PLoS Negl Trop Dis. 2014. PMID: 24968313 Free PMC article. Review.
-
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.PLoS Negl Trop Dis. 2015 Oct 2;9(10):e0004087. doi: 10.1371/journal.pntd.0004087. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26431253 Free PMC article.
-
High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.PLoS Negl Trop Dis. 2014 May 22;8(5):e2875. doi: 10.1371/journal.pntd.0002875. eCollection 2014 May. PLoS Negl Trop Dis. 2014. PMID: 24854196 Free PMC article.
-
Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient.Clin Investig. 1994 Dec;72(12):1041-7. doi: 10.1007/BF00577752. Clin Investig. 1994. PMID: 7711412
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials